Ioannis Kottakis
Medical Director Clinical Science at Swedish Orphan Biovitrum AG | Basel, Basel, Switzerland
Ioannis Kottakis’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Medical Director Clinical Science at Swedish Orphan Biovitrum AG in July 2023 - Present
Clinical Development and Medical Affairs Consultant at Helvetic Payroll in January 2022 - July 2023
Global Medical Head asthma at Novartis Pharma AG in July 2018 - December 2021
World Wide Medical Affairs Director at Novartis Pharma AG in September 2017 - June 2018
Head, Corporate Clinical Development; Global Program Head Bronchiectasis at ZAMBON SPA in June 2015 - August 2017
Global Program Medical Director ( Xolair / Telehealth/P38MAPKi) at Novartis Pharma AG in August 2013 - May 2015
Physician Project Leader COPD (Inhaled Triple; P38MAPKi) at GlaxoSmithKline in November 2011 - August 2013
Medical Director (Head Med Affairs,Clin Ops, Regulatory,PV, QA)/Member Gov Board of Directors at GlaxoSmithKline Greece in April 2007 - October 2011
Head, Corporate Clinical R&D at Chiesi Group in April 2004 - April 2007
Global Brand Medical Director at Novartis in August 2000 - August 2003
University of Athens, Medical School, MD, August 1978 to August 1984
Sotiria Hospital,Athens, Respiratory Medicine License, August 1989 to August 1992
Lehigh University, BS, August 1975 to August 1978
Supporting biotech startups with operational management and technical expertise
CMC Consultant at PsyLabs
(Dec 2024 – Present)
Head of Regulatory Business Operations, Compliance, Labeling and AdPromo
Head of Regulatory Operations, Compliance & Labeling at Sobi - Swedish Orphan Biovitrum Ag
(Jun 2022 – Present)
Clinical Database Consultant at Sobi - Swedish Orphan Biovitrum AB (publ)
Senior Consultant-Clinical Database Management at Sobi - Swedish Orphan Biovitrum AB (publ)
(Nov 2020 – Present)
SVP International Sobi AB, CEO Swedish Orphan Biovitrum Switzerland AG
EmaCo was acquired by Sobi from Novimmune in August 2019 and merged with Swedish Orphan Biovitrum Switzerland in October 2019. The company is Sobi‘s platform for research, development and commercialization of immunology therapies. The core asset, Gamifant® (emapalumab-lzsg)...
Global Regulatory Affairs, Swedish Orphan Biovitrum
Global Regulatory Affairs at Swedish Orphan Biovitrum
(Aug 2021 – Present)
Senior Product Manager | Haemophilia & Rare Diseases | Launch Excellence & Strategic Marketing (Germany)
- Commercial lead for hemophilia products in Germany, with responsibility for strategic planning and launch execution
- Development of compliant, high‑impact marketing and educational initiatives for healthcare professionals
Strategic focus on joint health and long‑term o...
What is Ioannis Kottakis email address?
Email Ioannis Kottakis at [email protected]. This email is the most updated Ioannis Kottakis's email found in 2026.
How to contact Ioannis Kottakis?
To contact Ioannis Kottakis send an email to [email protected]. (updated on July 2026)
What industry does Ioannis Kottakis work in?
Ioannis Kottakis works in the Pharmaceuticals industry.
